Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA...
Read moreInsulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA...
Read moreCHICAGO -- An investigational individualized vaccine for surgically resected melanoma demonstrated durable benefits in reducing the risks of recurrence and distant spread, 5-year follow-up of a randomized study showed. Adding...
Read moreThe costs of meeting a federal mandate to make research papers freely and immediately available to the public are exorbitant, and most agencies don't have adequate plans in place to...
Read moreDeveloped in partnership with the Our Partner In "Beyond Diagnosis: Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their discussion on communicating effectively...
Read moreTo chart how our brains change over the course of our lives, neuroscientists have focused largely on beginnings and endings: the rapid development and pruning of neural connections in childhood and adolescence, and...
Read moreTelescopes at the Square Kilometre ArraySKAO The following is an extract from our Lost in Space-Time newsletter. Each month, we dive into fascinating ideas from around the universe. You can sign up for Lost...
Read moreIn this series, MedPage Today is asking healthcare economists and policy experts the same questions about the high costs of U.S. healthcare. They'll discuss what they believe is working, what's...
Read moreThe MHRA has authorised rilzabrutinib for adults with ITP where prior therapies have failed, based on phase 3 data showing durable platelet response. Medscape News UK Source link : https://www.medscape.com/viewarticle/mhra-authorises-rilzabrutinib-adult-itp-2026a1000ibk?src=rss...
Read moreThe investigational ileal bile acid transporter (IBAT) inhibitor volixibat delivered better itch relief than placebo in patients with primary sclerosing cholangitis (PSC), data from a phase II randomized clinical trial...
Read moreThe U.S. Centers for Disease Control and Prevention said on Tuesday that many Americans suffered serious complications — including bacterial infections and, in some cases,... Reuters Health Information Source link...
Read moreSomething happened at graduation ceremonies this spring that should cause every health system CEO, hospital administrator, and digital health investor to rethink their development, implementation, and marketing strategies: college graduates...
Read moreOver the last 9 months, nurses have been protesting a federal regulation that they say would drive up student loan debt, exacerbate workforce shortages, and threaten patient access to care....
Read moreAlice Roberts has a new book out in JuneDavid Stock This is a month to look out for some powerful new books, with authors taking on challenges of all sorts...
Read moreA sweeping proposed rule that would transfer federal grantmaking decisions from scientific experts to senior political appointees is "dystopian," "disastrous," and a "flagrant assault on our democracy," scientists and health...
Read moreCARL COURT/AFP via Getty Images I’m sitting in a soundproof booth at an audiologist’s office, wearing headphones and straining to hear some faint electronic noises. When I think I’ve heard...
Read moreBeneath Earth’s surface, unusual compounds may existCLAUS LUNAU/SCIENCE PHOTO LIBRARY Deep below our feet, manganese may exist in a form we have never seen before, and this underground source of...
Read moreFor many patients, taking a controlled medication feels like any ordinary medical decision. You're prescribed something for sleep, anxiety, ADHD, or pain. You're counseled on risks and side effects. You...
Read moreCHICAGO -- Sacituzumab govitecan (SG, Trodelvy) added to pembrolizumab (Keytruda) extended a surrogate measure of long-term clinical outcomes compared with chemotherapy plus pembrolizumab in patients with PD-L1-positive metastatic triple negative...
Read moreShare on PinterestResearchers say that 90–120 minutes of strength training per week can help reduce the risk of early death. Image Credit: People Images/Getty ImagesA new study found that 90–120...
Read moreHome-based digital cardiac rehab platforms are reaching women, ethnic minorities, and deprived communities missed by conventional services, new data show. Medscape News UK Source link : https://www.medscape.com/viewarticle/home-cardiac-rehab-data-signal-wider-access-gains-2026a1000ict?src=rss Author : Publish...
Read more© 2022 NewsHealth.
© 2022 NewsHealth.